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ABSTRACT
RNA-Seq is a widely-used method for studying the behavior of genes under different biological
conditions. An essential step in an RNA-Seq study is normalization, in which raw data are adjusted
to account for factors that prevent direct comparison of expression measures. Errors in normal-
ization can have a significant impact on downstream analysis, such as inflated false positives in
differential expression analysis. An under-emphasized feature of normalization is the assumptions
upon which the methods rely and how the validity of these assumptions can have a substantial
impact on the performance of the methods. In this paper, we explain how assumptions provide
the link between raw RNA-Seq read counts and meaningful measures of gene expression. We ex-
amine normalization methods from the perspective of their assumptions, as an understanding of
methodological assumptions is necessary for choosing methods appropriate for the data at hand.
Furthermore, we discuss why normalization methods perform poorly when their assumptions are
violated and how this causes problems in subsequent analysis. To analyze a biological experiment,
researchers must select a normalization method with assumptions that are met and that produces
a meaningful measure of expression for the given experiment.
Key words: RNA-Seq; normalization; assumptions; differential expression; spike-in control; tran-
scriptome size
INTRODUCTION
The introduction of microarrays provided the ability to study many genes in an organism
under different biological conditions, with a dramatic reduction in expense and time from previous
methods [1]. More recently, high-throughput sequencing has become an affordable and effective
way of examining gene behavior and has been applied to a wide range of biological studies. For
example, very specific questions about transcriptomes and splicing can now be addressed [2], and
the study of techniques for the analysis of high-throughput sequencing data continues to be a hot
topic, involving researchers from biology, statistics, and computer science.
High-throughput sequencing with RNA, commonly referred to as RNA-Seq, involves mapping
sequenced fragments of cDNA. In RNA-Seq, the RNA is fragmented and then reversed transcribed
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to cDNA (or reverse transcribed then fragmented). These fragments are then sequenced, producing
reads which are aligned back to a pre-sequenced reference genome or transcriptome [2–4], or in some
cases assembled without the reference [3]. The number of reads mapped to a gene is used to quantify
its expression.
To convert raw read counts into informative measures of gene expression, normalization is
needed to account for factors that affect the number of reads mapped to a gene, like length [5], GC-
content [6], and sequencing depth [7]. Length and GC-content are within-sample effects, meaning
that they affect the comparison of read counts between different genes in a sample. Sequencing
depth, on the other hand, is a between-sample effect that alters the comparison of read counts
between the same gene in different samples. Here we focus on between-sample normalization, which
is needed to account for technical effects (differences not due to the biological conditions of interest)
that prevent read count data from accurately reflecting differences in expression [7]. In RNA-Seq, a
cDNA library is constructed and then a portion of the molecules are sequenced to produce reads [8].
Experimental variability, such as variability in the total number of molecules sequenced, can lead
to different total read counts in different samples; this is referred to as differences in sequencing
depth, and the total number of reads in a sample is the library size of that sample [9]. When one
sample has more reads than another, non-differentially expressed genes will tend to have higher
read counts in that sample [7] and so a correction is necessary. For applications requiring both
between-sample and within-sample normalization, performing both types of normalization may be
necessary; for example, Risso et al. recommend using within-sample GC-content normalization in
combination with between-sample normalization [6].
Many normalization schemes have been proposed to account for between-sample effects in RNA-
Seq data [9], and several attempts have been made to determine the best strategy [9–16]. However,
very little attention has been paid to the assumptions upon which the different normalization
methods rely. Several authors have identified situations in which a few highly expressed genes make
up a large proportion of the total reads [9,10,13], which could result in differences in distribution of
read counts among genes. Others have found cases in which most or all genes are up-regulated in
one condition [17–20]. These situations, especially a global shift in expression, violate assumptions
of many commonly-used methods and so result in errors in downstream analysis. Furthermore,
biological experiments in which assumptions are unwittingly violated may mean that there are flaws
in comparisons of normalization methods and in the conclusions drawn from these experiments.
As we have evidence of violated assumptions in some biological experiments, but not the extent to
which assumptions are violated in others, it has been suggested that many prior conclusions are
incorrect and a reanalysis of published results is necessary [21].
The goal of this paper is to present normalization methods in the context of their assumptions,
and to evaluate the effect and importance of assumptions on the performance of different normal-
ization methods. We believe that a focus on assumptions can aid in evaluating different methods,
and in choosing an appropriate method given knowledge of which assumptions are reasonable to
make for the experiment at hand. With this in mind, we group between-sample methods by the
assumptions they rely on and their strategy for normalization. We explain the reason the assump-
tions are necessary and the result of using a method when the assumptions do not hold. Finally,
we examine previous research that aims to determine which normalization method is better from
the perspective of why some methods perform better than other in specific situations.
GENE EXPRESSION AND NORMALIZATION
The goal of normalization is for differences in normalized read counts to represent differences
in true expression. Normalization is correct when the relationship between normalized read counts
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is correct. This essential purpose of normalization clearly depends on what we mean by “true
expression.” In a simple view of gene expression, DNA is transcribed to RNA, which is then
translated into protein. As discussed by Pachter [22], RNA-Seq read counts do not measure final
production of protein. Rather, sequencing technology quantifies the intermediate of gene expression:
RNA, often specifically mRNA. Given that the actual product of gene expression is never measured,
we consider the true expression of a gene to be the amount of mRNA/cell it produces.
This appears to be the definition commonly used in previous work, as prior research considers a
gene to be differentially expressed (DE) across different biological conditions if there is a difference
in the amount of mRNA/cell it produces under these conditions. For example, authors discussing
a global shift in expression talk about a global change in the absolute amount of RNA from a fixed
number of cells [23]. In this paper we view expression and differential expression in terms of absolute
quantities of mRNA/cell, and keeping this perspective in mind is important for understanding our
discussion of normalization methods and their assumptions. However, it is important to note that
other definitions of expression and differential expression are possible [24], and beginning with a
different definition may change which methods are appropriate for a given RNA-Seq experiment.
For example, for certain biological experiments one might be interested in detecting differences in
mRNA/transcriptome (that is, a gene’s proportion of mRNA out of all mRNA transcribed) rather
than mRNA/cell [24].
Considering differentially expressed genes is very helpful for understanding normalization. As
stated above, correct normalization will result in correct relationships between normalized read
counts. In terms of differential expression, this means that non-DE genes should on average have the
same normalized read counts across conditions, while DE genes should have normalized read counts
whose differences (ratios) across conditions represent the true differences (ratios) in mRNA/cell.
As with microarrays, a common use of RNA-Seq is to investigate the differential expression of
an organism’s genes under different biological conditions [2], but normalization is needed in any
RNA-Seq study where the relationship between normalized read counts must be correct, not just in
differential expression analyses. In this paper, for simplicity we restrict our examples to the most
basic case of two biological conditions, which will generally be referred to as A and B. Our results,
however, hold for any number of conditions.
Gene expression is measured with RNA-Seq using the number of reads aligned to each gene
under each biological condition [3]. However, a naive comparison of read counts for a given gene
under the different conditions is problematic for two reasons. First, the number of reads aligned
to a given gene in a given sample can be considered a random variable [25], and so read count
comparisons must take into account the variability of these random variables; an observed difference
in count could simply be due to random chance. Second, the total number of reads can vary across
samples [2], and so a large difference in a gene’s read count between different conditions may
simply be the result of differential coverage, rather than of differential expression. It is the second
problem that necessitates normalization of read counts before differential expression analysis can
be performed [2,4].
Normalization is an essential step in an RNA-Seq analysis, in which the read count matrix is
transformed to allow for meaningful comparisons of counts across samples. With the advent of
RNA-Seq technology it was initially believed that normalization would not be necessary [3], but
normalization has been found to be indispensable for correct analysis of RNA-Seq data. Indeed,
Bullard et al. [10] found that the normalization procedure used in a differential expression pipeline
had the largest impact on the results of the analysis, even more than the choice of test statistic
used in hypothesis tests for differential expression.
Another reason normalization is required is that the proportion of mRNA corresponding to a
given gene may change across biological conditions. In the sample of molecules sequenced, the
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number of molecules (and so by extension the number of reads) corresponding to a given gene is
tied to that gene’s share of the population of molecules available for sequencing. Hence, when there
are a few genes that are highly expressed in only one of the conditions, the few genes will make
up a greater share of the total molecules and so a smaller fraction of the reads will be left for the
other genes [7]. This can cause the false appearance of differential expression for the non-DE genes,
and normalization is needed to account for this difference. A visualization of such a situation is
presented in Figure 1. Of the three genes, one is up-regulated while the other two are non-DE
(Figure 1(a)). The one highly expressed gene leads to differences in shares of the proportion of
mRNA for each gene (Figure 1(b)) which in turn causes differences in the share of reads aligned
to each gene, even if the total number of reads is the same in each condition (Figure 1(c)). If
the differences in read share are not corrected by normalization (Figure 1(d)) then the apparent
fold change for every gene will be wrong (Figure 1(e)). Correct normalization, on the other hand,
equilibrates the read counts for the two non-DE genes (Figure 1(d)) and thereby leads to accurate
observed fold changes (Figure 1(e)).
As normalization methods have developed, it has become clear that initial approaches fail in
cases of a shift in expression for many or all genes [23]. In cases like Figure 1, a small number
of highly expressed genes creates the appearance that non-DE are differentially expressed, but the
false DE calls may be corrected by normalizing read counts so that the expression levels of non-DE
genes are equivalent. In contrast, in the case of a global shift in expression it may appear that
differentially expressed genes are non-DE or that up-regulated genes are down-regulated [23]. An
example is presented in Figure 2. All genes are up-regulated two-fold under condition B (Figure
2(a)), but roughly the same number of molecules are sequenced (Figure 2(b)). This conceals the
fact that one condition results in twice as much total expression, and the only differences in read
counts between the two conditions is due to technical variability (e.g. sequencing depth) (Figure
2(c)). Conventional normalization approaches account for the technical differences, resulting in the
same normalized read counts under each condition (Figure 2(d)). Conventional normalization fails
to reflect the two-fold up-regulation under condition B, and examining the observed fold changes
(Figure 2(e)) it appears that neither gene is differentially expressed when in truth both are. A
further need for normalization is therefore in cases of global shifts in expression, in which it is
necessary to take into account the differences in overall expression between conditions.
To address the variety of needs for normalization, a corresponding variety of normalization
methods has been developed. To correctly normalize, each method requires one or more assump-
tions about the experiment and gene expression. Assumptions are necessary for converting read
counts into meaningful measures of expression. In the following sections we organize normalization
methods into groups of methods that rely on similar assumptions.
NORMALIZATION METHODS AND ASSUMPTIONS
Here we group normalization methods that have similar assumptions and approaches to normal-
ization. Short descriptions of the methods are provided; more detailed information on the method
specifics is available in the Supplementary Information.
Recall that for our purposes, a gene is differentially expressed across a set of conditions if that
gene produces different levels of mRNA/cell under the different conditions. For a normalization
method to work, the normalized read counts must be representative of the true mRNA/cell values.
That is, if a gene produces twice as much mRNA/cell under condition A as under condition B,
then the normalized read count for that gene should on average be twice as big under condition A
as under condition B. However, RNA-Seq, on the other hand, initially produces relative measures
of expression [22]. As shown in Figure 2, the number of reads aligned to a given gene reflects
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Figure 1: One highly expressed gene. An experiment is performed with conditions A and B to compare
expression for the three genes (1, 2, and 3). (a) Gene 3 is two-fold up-regulated under condition B, while
the other genes are not differentially expressed; the quantity of mRNA/cell (in bp) is the same for Genes 1
and 2, but is twice as high for Gene 3 under condition B. (b) Because of the change in expression of Gene
3, the shares of mRNA in the cell are different between conditions. Under condition A each gene gets 1/3,
whereas under condition B Gene 3 gets 1/2 while the other two get 1/4. (c) Differences in shares of mRNA
are reflected in the shares of reads. Each sample has the same total number of reads, but the distribution
is different between the conditions, matching the distribution of mRNA in (b). (d) When no normalization
is performed, there are apparent differences in read counts for all three genes. Total Count normalization
produces the exact same result as no normalization at all, since the total read count for each sample is the
same. In truth there is no difference in expression for Genes 1 and 2, and the relative count for Gene 3 should
be higher than found by no normalization or Total Count normalization. Correct normalization, therefore,
makes the read counts of the non-differentially expressed genes equivalent, which also makes the relative
expression of Gene 3 correct. (e) No normalization and Total Count normalization fail to equilibrate the
read counts of the non-DE genes, resulting in each gene appearing differentially expressed, and the truly DE
gene (Gene 3) having the wrong fold change. Correct normalization reveals no difference in expression for
the non-DE genes and the correct fold change for Gene 3.
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Figure 2: Global shift in expression. There are two genes, and an experiment is performed to compare
expression between condition A and condition B. (a) There is global up-regulation under condition B vs.
condition A, with both genes having twice the expression under condition B. Within each condition, the two
genes produce the same amount of mRNA/cell (measured in bp). (b) In the RNA-Seq experiment, the same
number of molecules are sequenced from each of the two samples. Proportionally, the mRNA composition
is the same under each condition, so the composition of molecules sequenced is also the same. Within each
condition, the two genes produce the same amount of mRNA (in bp) but Gene 2 is 4/5 the length of Gene
1, so must produce 5/4 the number of molecules that Gene 1 does. (c) Sequenced reads are aligned to the
reference genome and mapped to each gene. The distribution of reads is the same in each sample, but by
chance the sample for condition A happens to have more reads in total. (d) Normalization is performed,
which removes the differences in read count from technical variability, so the read count for each gene is
the same across conditions. (e) Because the normalized read counts are the same, the observed fold change
for each gene is 1, indicating no differential expression. However, genes are really twice as expressed under
condition B and so in truth we should see half the expression when comparing A to B.
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Figure 3: Differential expression and (a)symmetry. There are six genes, and two experimental condi-
tions. (a) Differential expression is asymmetric (3 up-regulated genes under condition A, 1 under condition
B). The total mRNA/cell (summed over the six genes) is the same under both conditions. (b) Differential
expression is asymmetric. The total mRNA/cell is different (less total mRNA/cell under condition B). (c)
Differential expression is symmetric (2 up-regulated genes under each condition). The total mRNA/cell is
the same under both conditions. (d) Differential expression is symmetric. The total mRNA/cell is different
(more total mRNA/cell under condition B).
the sequencing depth and that gene’s share of the population of mRNA molecules. We shouldn’t
expect a gene with twice as much mRNA/cell to have twice the number of reads. To correctly
normalize, then, we must make some assumptions so that measures of relative expression (raw read
counts) can be translated into measures of absolute expression (normalized read counts). Different
groups of normalization methods discussed here take different approaches, and so require different
assumptions to produce correctly normalized values. These assumptions often deal with the total
amount of mRNA/cell or the amount of symmetry in the differential expression.
We say that differential expression is symmetric between two conditions when the number of
genes up-regulated in each condition is equal. Figure 3 demonstrates the four possible combinations
of symmetry/asymmetry and same/different total mRNA/cell. Figure 3 will be referenced to
illustrate situations in which assumptions are and are not met.
Normalization by Library Size
The normalization by library size aims to remove differences in sequencing depth simply by
dividing by the total number of reads in each sample [9].
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Assumptions
Same total expression: the amount of total expression is the same under the different exper-
imental conditions. That is, each condition has the same amount of mRNA/cell. Figure 3(a) and
Figure 3(c) show examples in which this assumption holds.
Methods
Total Count normalization [9] divides each read count by the number of reads in its sample.
The RPKM (reads per kilobase per million mapped reads) [26] and FPKM (fragments per kilobase
per million mapped fragments) [27] methods are essentially the same as Total Count normalization,
but with the added component of accounting for gene length as well. ERPKM is a variant of
RPKM that replaces gene length with an effective length [12].
Motivation
After dividing by library size, the normalized counts reflect the proportion of total mRNA/cell
taken up by each gene. If the total mRNA/cell is the same across conditions, this proportion
reflects absolute mRNA/cell for each gene.
Normalization by Distribution/Testing
If technical effects are the same for DE and non-DE genes, then normalization could be done
by equilibrating expression levels for non-DE genes. This set of methods attempts to capture
information from non-DE genes. Normalization by distribution compares distributions (either of
read counts or some function of read counts) across samples; normalization by testing attempts to
detect a set of non-DE genes through hypothesis testing.
Assumptions
1. DE and non-DE genes behave the same: technical effects are the same for DE and
non-DE genes.
2. Balanced expression: there is roughly symmetric differential expression across conditions
(same number of up-regulated and down-regulated genes). This assumption holds in Figure
3(c) and Figure 3(d). Normalization by testing can tolerate a larger difference in number
of up- and down-regulated genes for higher proportions of DE than can normalization by
distribution (see Figure 6).
Methods
Normalization by distribution: Quantile normalization [28] forces the distribution of the nor-
malized data to be the same for each sample by replacing each quantile with the average (or median)
of that quantile across all samples. Other methods do not force all quantiles to be the same, but
instead focus on a specific quantile. Upper Quartile normalization [10] divides each read count
by the 75th percentile of the read counts in its sample. Median normalization [9] is essentially the
same, but uses the median rather than the 75th percentile. The DESeq normalization method [25]
finds the ratio of each read count to the geometric mean of all read counts for that gene across all
samples (the denominator serving as a pseudo-reference sample [25]). The median of these ratios
for a sample, called the size factor, is used to scale that sample. This idea was expanded in the
CuffDiff 2 software; CuffDiff normalization calculates internal and external size factors using the
DESeq approach. The internal size factors are found for each sample by only considering other
samples performed under the same biological condition when taking the geometric mean, while the
external size factors are calculated after normalization by the internal size factors. The TMM
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(Trimmed Mean of the M-values) [7] approach is to choose a sample as a reference sample, then
calculate fold changes and absolute expression levels relative to that sample. The genes are trimmed
twice by these two values, to remove differentially expressed genes, then the trimmed mean of the
fold changes is found for each sample. Read counts are scaled by this trimmed mean and the total
count of their sample. Note: the edgeR package [29] uses TMM normalization, and so TMM could
reasonably be called edgeR normalization instead. However, the name TMM seems to be more
commonly used in the literature, and so we use it here. Median Ratio normalization (MRN) [14]
is a method similar to TMM, with the goal of being more robust. In MRN, read counts are divided
by the total count of their sample, then averaged across all samples in a condition for a given gene.
This produces an average count-normalized value for each gene and each condition, and the median
of the ratios of these values between conditions is taken. The original counts are then normalized
by this median and their library size.
Normalization by testing: PoissonSeq [30] uses an iterative process that alternates between
estimating a set of non-differentially expressed genes, and estimating the scaling factor for each
sample using that set. Given estimates of the scaling factor, expected values for the read counts can
be determined and non-DE genes are identified using a χ2 goodness-of-fit test. A similar iterative
strategy is implemented by DEGES (Differentially Expressed Gene Elimination Strategy) [11],
which alternates between calculating scaling factors from a set of genes identified as non-DE, and
estimating which genes are non-DE using differential expression hypothesis testing.
Motivation
Non-DE genes should have, on average, the same normalized counts across conditions. Clearly,
we want to normalize in order to equilibrate the non-DE genes. If technical effects impact non-DE
genes and DE genes alike, then we can normalize all genes with the same normalization factor as
the non-DE genes. So, we need to compare the non-DE genes; assuming balanced expression means
we can estimate the differences in read counts between non-DE genes across samples.
Normalization by Controls
Controls are needed for normalization when the assumptions of other methods are violated. For
example, Figure 2 demonstrates how a global shift in expression can go undetected. When controls
are used, such as the negative controls illustrated in Figure 4, then it is possible to correctly
normalize by performing normalization on the controls. Since the controls are not affected by the
biological conditions but the same amount of controls/cell are present in each condition (Figure
4(a)) then different numbers of control molecules are sequenced (Figure 4(b)). This leads to a share
of the reads reflective of the share of mRNA for the control (Figure 4(c)). By normalizing on the
control, the correct levels of expression are seen (Figure 4(d)) and so accurate fold changes are
observed (Figure 4(e)).
Assumptions
1. Existence of controls: The controls needed for the experiment do in fact exist, and their ex-
pression behaves as expected (e.g., for negative controls they are non-DE under the conditions
of the experiment).
2. Controls behave like non-control genes: The technical effects for the controls in some
way reflect the technical effects for all the genes, so that the controls can be used for normal-
ization.
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Figure 4: Use of negative controls with shift in expression. Two genes are investigated for differential
expression between condition A and condition B. A negative control is used for normalization (could be a
known non-DE gene or spike-in control). (a) Both non-control genes are up-regulated under condition B
vs. condition A, having twice the expression under condition B. As a negative control, the control has the
same expression under both conditions. (b) In the RNA-Seq experiment, the same number of molecules is
sequenced from each sample. As the control has a smaller share of the mRNA in condition B, there are
fewer control molecules in the sample for condition B. (c) Variability leads to differences in the total read
count for the two samples. The share of the reads aligned to the control is the share of mRNA from the
control. (d) The control should have the same expression in both conditions, so normalization is performed
to equalize the normalized read count for the control, resulting in normalized read counts that reflect the
correct mRNA/cell levels. (e) Because normalized counts correctly reflect mRNA/cell, the observed fold
change agrees with the truth.
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Methods
Housekeeping genes: Housekeeping genes (HG) are genes which play a role in the basic
functions of a cell [31], and so are believed to be non-DE under the biological conditions of interest
[10, 31]. HG normalization assumes that these genes are truly not differentially expressed, and
furthermore that they are affected by technical effects the same way as DE genes. Normalization
using housekeeping genes can either equalize the read count of the gene (if one housekeeping gene)
[10] or perform a conventional normalization procedure on a set of housekeeping genes [9].
Conventional normalization with spike-ins: A set of synthetic spike-in controls is available
through the ERCC [32], and these can be used instead of housekeeping genes. The use of spike-ins
with conventional methods assumes that the spike-ins are not affected by the biological conditions
under investigation, and that they have the same technical effects as the real genes [33]. Conven-
tional normalization methods, such as Upper Quartile, may be applied to the spike-ins [33], as
with HG controls. The conventional normalization methods are applied only to the spike-ins, and
then used to calculate normalization factors for all genes. One approach is proposed by Love´n et
al. [23], which uses cyclic loess normalization on the spike-ins (CLS). Spike-ins are added to RNA
in proportion to the number of cells from which RNA is extracted. Then, cyclic loess normalization
is performed on the RPKM values (more details can be found in the Supplementary Information).
The loess curve is fit using only the spike-ins, but used to adjust all RPKM values so that the other
genes are normalized with the spike-in information, which is not affected by differential expression.
Factor analysis of controls: To address perceived problems with the use of spike-ins, Remove
Unwanted Variation (RUV) [33] uses factor analysis to remove factors of unwanted variation
in RNA-Seq data. Using a set of negative control genes or samples, singular value decomposition is
used to estimate a matrix for the factors of unwanted variation. Normalization to remove the factors
of unwanted variation is then performed. It is divided into three sub-methods: RUVg, RUVs, and
RUVr. The two assumptions listed above indicate slightly different things for the different sub-
methods, and RUVr doesn’t actually require controls (it is an adaptation of the RUV method to
be used when controls are not available) [33]. Here we list the meaning of the assumptions for each
of the three sub-methods:
1. RUVg. Existence of controls: negative controls exist (non-DE across conditions). Controls
behave like non-control genes: the factors of unwanted variation for the controls span the
same space as the factors for the entire set of genes.
2. RUVs. Existence of controls: negative controls exist (non-DE across conditions) and there
are also negative control samples (expression not related to biological condition). Controls
behave like non-control genes: the factors of unwanted variation for the controls span the
same space as the factors for the entire set of genes, and the factors of unwanted variation
are not correlated with experimental condition.
3. RUVr. Does not require existence of controls. Assumes that factors of wanted variation are
known (i.e., the design matrix) and the factors of unwanted variation are not correlated with
experimental condition.
Motivation
Controls should be non-DE across conditions and hence on average, normalized counts for
the controls should be the same across conditions. If technical effects impact controls like they
impact genes, then we can apply the adjustment for the controls to all genes. The reasoning for
normalization by controls is similar to normalization by distribution/testing, but in the former it
is assumed that an explicit set of controls is known, while in the latter we aim to capture the
information from non-DE genes without knowing beforehand which genes are non-DE.
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IMPORTANCE OF THE ASSUMPTIONS
At first glance it makes sense that correcting for differences in sequencing depth can be done
simply by library size normalization, which works if the total amount of mRNA in each cell is the
same across experimental conditions. Then, a gene which produces the same amount of mRNA
under each condition will produce the same proportion of total mRNA in each condition. We thus
expect the same proportion of reads to be aligned to that gene under each condition, and Total
Count normalization gives us exactly the proportion of reads aligned to each gene. Likewise, dif-
ferences in expression correspond to differences in proportion of reads in the sample. However,
differences in total mRNA/cell can lead to both failing to detect differentially expressed genes (Fig-
ure 2) and incorrectly calling non-DE genes differentially expressed (Figure 1) when normalization
by library size is performed in situations where total mRNA/cell is not constant.
On the other hand, normalization by distribution and by testing are impacted by differences
in the number of up-regulated vs. down-regulated genes, but not by the relative amounts of
mRNA/cell. The greater the disparity between the number of up-regulated genes and the number
of down-regulated genes under a given condition, the higher the asymmetry of the differential
expression under that condition. Both Figure 1 and Figure 2 show differences in total expression
(mRNA/cell) between the two conditions, but there is much more asymmetry in Figure 2 (that is,
100% of the genes are up-regulated). Accordingly, normalization by distribution and by testing can
handle differences in mRNA/cell in the case of a few highly expressed genes (small asymmetry), but
not a global shift in expression (large asymmetry). If there are only a few differentially expressed
genes, these DE genes will not do much to change the estimated normalization factor. For example,
the Upper Quartile normalization strategy compares the 75th percentile of read counts between
samples. If the 75th percentile of all the read counts is similar to the 75th percentile of the non-DE
read counts, this is a reasonable approach. The normalization statistic for all genes will be similar
to the normalization statistic for non-DE genes if there are only a few differentially expressed
genes. The two statistics will also be similar when there is a small proportion of asymmetry. When
differential expression is mostly symmetric, the values for differentially expressed genes should
more or less balance out on either side of the statistic for non-DE genes, so that the statistic for
all genes is close to the statistic for non-DE genes. A small proportion of asymmetry can allow
distribution/testing methods to tolerate higher proportions of differential expression.
Knowledge of the assumptions made by each normalization method allows for good predictions
of which biological experiments are suitable for each method. Normalization by library size should
work well when total mRNA/cell is equivalent across conditions, regardless of the amount of asym-
metry (Figure 3(a) and Figure 3(c)). On the other hand, normalization by distribution/testing
should generally work well when there is symmetry, regardless of differences in mRNA/cell (Figure
3(c) and Figure 3(d)). When there is both asymmetry and different levels of total mRNA/cell
(Figure 3(b)), we expect both sets of methods to perform poorly.
To demonstrate this, we examined the performance of several normalization methods on simu-
lated data (Figure 5 and Figure 6). For the simulations, we chose methods which were representative
and generally perform well in the literature, as summarized in Table 1 (except for Total Count nor-
malization, as all normalization by library size methods perform poorly in the literature). We
used Total Count, DESeq, TMM, PoissonSeq, DEGES, and finally Oracle normalization that uses
the true normalization factor known from the simulation parameters. To measure how well the
methods performed normalization, we used a method similar to Maza et al. [14] and calculated the
mean squared error (MSE) of the log fold change for non-DE genes (Figure 5), comparing each
observed log fold change to 0. As these genes are not differentially expressed, if normalization is
performed correctly then the log fold change between samples of different conditions should be
close to 0. Oracle normalization provides the baseline for the MSE under perfect normalization;
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methods which track closely with the Oracle are performing well.
Figure 5 shows the results of the simulations, confirming that the methods perform as expected.
Total Count normalization follows the Oracle closely when there is the same total mRNA/cell, but
diverges quickly when there is different mRNA/cell. DESeq, TMM, and DEGES perform well
when there is symmetry, for all proportions of differential expression. PoissonSeq does well under
symmetry until too high a proportion of differential expression is reached, at which point it diverges.
This is likely due to the fact that PoissonSeq normalization uses a set of genes of a fixed size for
normalization; when the proportion of differential expression is too high, the set necessarily contains
differentially expressed genes that skew the normalization estimate. When there is asymmetry,
the normalization by distribution/testing methods can tolerate a small proportion of differential
expression but eventually reach a break-down point.
The effects on downstream analysis of applying the different normalization methods are shown
in Figure 6, which show empirical false discovery rate (eFDR) measures for each method after
testing for differential expression (note: the downward trend in the Oracle eFDR is due to the
use of the Benjamini-Hochberg procedure to control FDR, which is conservative and controls at a
level directly related to the proportion of true null hypotheses, i.e. non-DE genes). When methods
normalize correctly, as shown in Figure 5, the subsequent tests for differential expression are able to
control the false discovery rate. However, when normalization fails and the observed fold changes
depart sufficiently from the truth, the result is inflated false positives. This illustrates how heavily
analysis relies on correct normalization, which in turn relies on assumptions. When the assumptions
are violated, normalization fails (Figure 5) and as a result so does the downstream analysis (Figure
6).
Simulation Details
To assess the downstream results of violating the assumptions of different normalization meth-
ods, simulations were run in which the average mean squared error (MSE), on non-DE log fold
changes, and average empirical false discovery rate (eFDR) were computed for different propor-
tions of differential expression (proportion of genes which are truly DE), amounts of asymmetry,
and relative amounts of mRNA/cell. The code for the simulations and the plots of the results can
be found at (https://github.com/ciaranlevans/rnaSeqAssumptions), and was adapted from the R
code used in the simulations of Law et al. [34].
Four sets of simulations were performed, one for each combination of asymmetry vs. symmetry
and same mRNA/cell vs. different mRNA/cell. In each simulation, read count data was generated
then normalized according to one of six different methods: DEGES, DESeq, Oracle (normalization
with the true scaling factors, used for benchmarking other normalization methods), PoissonSeq,
TMM, and Total Count. The normalization methods were selected to represent different types of
normalization: by library size (Total Count), by distribution (DESeq and TMM), and by testing
(PoissonSeq and DEGES). DESeq and TMM were chosen to represent normalization by distribution
methods as they are widely studied and generally perform well relative to other methods (Table 1).
Simulated RNA-Seq data was generated, then each normalization method was performed. After
normalization, two normalized columns of the read count matrix (one from each condition) were
compared to produce log fold changes for the non-DE genes. These observed log fold changes
should be close to 0, so the MSE was calculated by averaging the squared log fold changes for
the non-DE genes. Differential expression hypothesis testing was performed on the data for each
normalization method. Testing was done separately from normalization, and was performed with
the DESeq2 [35] package after normalization with each method (the data was not re-normalized with
DESeq2). As in DESeq2, and as is common in differential expression studies, p-values were adjusted
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Figure 5: Impact of amount of asymmetry and amount of mRNA/cell on fold change estimates.
These plots show the average log fold-change MSE for non-DE genes of several methods. Simulated data is
used, with varying proportions of differential expression (5% to 95%). Genes simulated to be non-DE should
have an observed log fold-change close to 0; the MSE is thus calculated by averaging the squared observed
log fold-changes for each non-DE gene (treating the true log fold-change as 0). Because of variability
in the generation of read count data, the observed log fold-change will in general not be exactly 0, so
the Oracle normalization method (normalizing the data with the correct normalization factors given the
simulation) serves as a baseline. Methods with MSEs that closely follow those of Oracle normalization are
doing well. Asymmetric differential expression was simulated as 75% of the set of DE genes up-regulated
in one condition and 25% up-regulated in the other. Under symmetric differential expression, 50% of DE
genes are up-regulated in each condition. For simulations with the same mRNA/cell, non-DE genes had the
same proportion of reads in each condition; simulations with different mRNA/cell resulted in non-DE genes
having different shares of the reads in the different conditions.
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Figure 6: Impact of amount of asymmetry and amount of mRNA/cell on error control. These
plots show the average empirical FDR of several methods on simulated data with varying proportions of
differential expression (5% to 95%). The simulations are performed with two conditions. Asymmetric
differential expression was simulated as 75% of the set of DE genes up-regulated in one condition and 25%
up-regulated in the other. Under symmetric differential expression, 50% of DE genes are up-regulated in
each condition. For simulations with the same mRNA/cell, non-DE genes had the same proportion of reads
in each condition; simulations with different mRNA/cell resulted in non-DE genes having different shares of
the reads in the different conditions. The black dashed line is at 0.05, the nominal FDR using the Benjamini-
Hochberg adjustment. Deviations of the oracle value from the nominal value (starting above 0.05 and falling
below as the proportion of DE increases) are a result of DESeq2 hypothesis testing and the conservativeness
of Benjamini-Hochberg.
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using the Benjamini-Hochberg procedure for FDR control [36] (see Supplementary Information
for more details). Using the adjusted p-values, and knowledge of which genes were simulated to
be differentially expressed, the average eFDR (observed proportion of false discoveries out of all
discoveries) was calculated across 50 repetitions.
Simulations begin by creating initial proportions of expression, representing the proportion of
the total expression for each gene and each sample, with 1000 genes and 10 samples (5 samples
per condition). A random subset of genes is chosen to be differentially expressed, with the number
determined by the specified proportion of differential expression.
Asymmetry, same mRNA/cell: Differential expression is asymmetric (more genes up-
regulated under one condition than the other), but the absolute expression is the same for each
condition. 75% of DE genes were 2-fold up-regulated under condition A, and 25% were 4-fold
up-regulated under condition B.
Asymmetry, different mRNA/cell: Differential expression is asymmetric, and the absolute
expression is different under the different conditions. 75% of DE genes were 2-fold up-regulated
under condition A, and 25% were 2-fold up-regulated under condition B.
Symmetry, same mRNA/cell: Differential expression is symmetric (same number up-
regulated under each condition), and the absolute expression is the same for each condition. 50%
of DE genes were 2-fold up-regulated under condition A, and 50% were 2-fold up-regulated under
condition B.
Symmetry, different mRNA/cell: Differential expression is symmetric, but the absolute
expression is different under the different conditions. 50% of genes are 4-fold up-regulated under
condition A, and 50% are 6-fold up-regulated under condition B.
EVALUATION OF METHODS AND ASSUMPTIONS
Several papers have investigated the different normalization methods described in the previous
section. Table 1 summarizes these comparisons by giving approximate rankings of the methods
evaluated in each comparison. Here we expand on these rankings to remark on several key ideas.
Differences in mRNA/cell result in poor performance of library size normalization.
As shown in Table 1, in many comparisons Total Count and RPKM/FPKM perform worse than all
other methods, and several authors expressly recommend against its use [9]. A likely cause of this
is that in these evaluations, the assumption required for library size normalization (same amount of
mRNA/cell) is violated. For example, Dillies et al. [9] observed that a few highly expressed genes
had a large share of the read counts in M. musculus data they compared. Bullard et al. [10] and
Lin et al. [13] reported similar findings. Bullard saw 50% of the reads concentrated in 5% of the
genes, and Lin found 50% of the reads in 45 genes for male flies and 186 genes for female flies.
With such a large proportion of the reads aligned to a small fraction of the genes, if these genes
are differentially expressed it is likely that there will be different amounts of mRNA/cell across the
conditions, and Bullard et al. [10] did observe that the highly expressed genes were differentially
expressed.
DESeq and TMM generally perform well, but validity is not certain. Dillies et al. [9],
for example, note that DESeq and TMM are the only methods that perform well both with the
ability to detect differentially expressed genes, and with controlling false positives. This supports
the conclusion of Bullard et al. [10], who concluded that normalization has the biggest impact on
detection of differentially expressed genes.
Given that several authors have found that a few highly expressed genes have a large share of
total expression [9,10,13] and these genes may be differentially expressed, it is clear that assuming
the same amount of mRNA/cell is not always reasonable. The good performance of DESeq and
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Paper
Goal
Evaluation Criteria Approximate Ranking
Global
compare
Equiv. normalized count distribution between replicates
(real data); variance of normalized counts within condition
(real data); equiv. expression of housekeeping genes (real
data); agreement on DE calls (real data); false positives
and power (simulation). [9]
DESeq & TMM
UQ & Med
Q
RPKM & TC
Introduces
UQ
DE detection compared to qRT-PCR (ROC curves) (real
data); variability between replicates after normalization
(real data); bias in fold-change estimation compared to
qRT-PCR (real data). [10]
UQ
Q
TC
Introduces
MRN
False positives, false negatives, and power (simulation);
MSE of expression fold-change estimates (simulation);
number of DE calls and agreement on DE calls (real data).
[14]
MRN
DESeq & TMM
TC
UQ & Med
FPKM
Global
compare
Equiv. normalized count distribution between replicates
(real data); variance of normalized counts within condition
(real data); agreement on DE calls (real data); variability of
results under different filtering techniques (real data). [13]
DESeq
TMM
UQ, Med, & Q
RPKM & TC
(RUVg considered, but as-
sumptions not met)
Global
compare
Correlation between normalized counts and qRT-PCR data
(real and simulated data). [12]
All were equivalent
(DESeq, Med, Q, RPKM
and ERPKM, TMM, UQ)
Global
compare
Bias and variance in fold change estimation (compared to
housekeeping genes) (real data); sensitivity and specificity
in DE calls (using genes believed to be DE and non-DE)
(real data); prediction of DE genes (real data); agreement
on DE calls (real data). [16]
DESeq
PS
Q
UQ
TMM
Global
compare
Clustering of normalized counts agrees with condition (real
data); correlation between fold change estimates and qRT-
PCR fold changes (real data). [15]
All were equivalent
(DESeq, PS, UQ, TMM,
Q, CuffDiff)
Introduces
DEGES
ROC curves and AUC (real and simulated data). [11] DEGES strategy using
a normalization method
generally performed bet-
ter than that method by
itself
Introduces
CLS
Observed fold change for normalized data (real data). [23] CLS
RPKM
Introduces
RUV
PCA (real data); variance and distribution of normalized
data (real data); distribution of p-values (real data); clus-
tering and proportion of reads mapping to spike-ins (real
data); MA plots (real data); ROC curves (real data); com-
parison with qRT-PCR (real data). [33]
RUV
(UQ, CLS, RPKM, TMM,
DESeq, & Q)
Table 1: Literature comparing normalization methods. Several papers which include comparisons
of DE assumption normalization methods are summarized here. Short descriptions of the criteria used to
evaluate the normalization methods are provided, and the final results of the paper are condensed into an
approximate ranking of the methods considered (best performing methods at the top). These rankings are
not explicit in all papers and for some have been inferred from the paper’s discussion of the strengths and
weaknesses of the different methods. Abbreviations: UQ = Upper Quartile, Med = Median, Q = Quantile,
TC = Total Count, MRN = Median Ratio, PS = PoissonSeq, CLS = Cyclic Loess on Spike-ins.
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TMM in these studies suggests that perhaps their assumptions (DE and non-DE genes behave the
same, balanced expression) are fairly reasonable, or at least not too violated, for the data analyzed
in the comparisons. However, it is possible that for the real data analyzed in these comparisons there
is a global shift in expression that is not picked up by these normalization methods. For example,
a global shift has been observed in DE analysis with low and high c-Myc conditions [19, 20], and
this shift was undetected without the use of spike-in controls [23]. Other researchers [17, 18] have
found similar global up-regulation when using spike-ins, and it has been suggested that such shifts
were not detected by previous research due to lack of proper normalization [18]. Even qRT-PCR,
often treated as a “gold standard” for evaluating the performance of DE analysis methods, might
not be able to detect a global shift without controls. Normalization for qRT-PCR often relies
on housekeeping genes [10, 37, 38]. In the absence of non-DE genes, as occurs with a global shift
in expression, qRT-PCR results might not be accurate. Furthermore, the use of PCR as a gold
standard for evaluation of normalization methods has been called into question, as despite being
highly accurate, PCR can contain errors [39]. Hence, for methods which normalize by distribution
or by testing, it is difficult or impossible to know whether their assumptions have been met without
additional information.
Potential lack of housekeeping genes. The possible absence of housekeeping genes poses
a problem for HG normalization of RNA-Seq data as well as PCR data. While Bullard et al. [10]
found that HG normalization performed equivalently to UQ, the housekeeping gene they used
(POLR2A) was selected based on previous studies and they caution that such information may
not always be available. Dillies et al. [9] also selected housekeeping genes from previous research,
and state that one cannot be certain housekeeping genes will always be non-DE. As mentioned
above, several authors have found global shifts in expression which would leave few, if any, non-DE
housekeeping genes for use in normalization [17–20].
External controls may be needed. In the case of a global shift in expression, the assump-
tions are violated for normalization methods that do not rely on external controls. Global up-
regulation necessarily leads to different amounts of mRNA/cell (library size normalization), highly
asymmetric expression (distribution/testing normalization), and an absence of non-DE genes (HG
normalization). Without the use of external controls, it is possible that many experiments have
resulted in incorrect conclusions [21]. Normalization with spike-in controls attempts to rectify the
problems of asymmetry, by relying on genes/spike-ins which should have the same expression under
the different conditions.
Mixed performance of spike-ins. As we have seen, these methods come with their own set
of assumptions, and it is not clear that these assumptions can always be trusted. In an assessment
of ERCC spike-in controls, Jiang et al. found that only small fractions (0.5% and 0.01%) of spike-in
reads were incorrectly aligned to the actual genome of the organisms in their experiment (Drosophila
and humans) [32]. This indicates that as desired, there will be little error introduced into the read
counts by the controls. Furthermore, Jiang et al. found a linear relationship between the amount
of spike-in and read count [32], which is evidence that the spike-in read counts are representative
of expression level. However, Risso et al. [33] found violations of both assumptions necessary for
basic spike-in normalization (spike-ins are non-DE across conditions and have the same technical
effects as genes), and Qing et al. [40] found that read counts for the spike-ins depended in part on
the mRNA enrichment protocol used in the experiment.
Recommendations: appropriate method depends on DE definition and assump-
tions. Different circumstances call for different normalization methods. Correct normalization
should cause non-DE genes to have the same (expected) normalized read count across conditions.
This requires a definition of differential expression. In this paper, we defined differential expression
in terms of differences in mRNA/cell across conditions, and it appears that this is the definition used
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in previous research evaluating normalization methods. Consequently, the majority of the commen-
tary and recommendations presented here is in the context of mRNA/cell differential expression.
However, other definitions of differential expression are possible and may be appropriate/necessary
in certain conditions [24]. One alternative is to define a gene as differentially expressed if its share
of mRNA in the transcriptome is different across conditions; this bases differential expression on
relative, rather than absolute, measures of expression. The mRNA/transcriptome definition may
be appropriate in some circumstances: Ignatov et al. [41] performed an experiment which found
down-regulation of every gene when using the mRNA/cell definition, so they chose instead to look
for differences in per transcriptome expression.
Choosing a normalization method depends on the definition of differential expression. For exam-
ple, library size normalization generally performs poorly when defining DE in terms of mRNA/cell,
but should produce exactly the desired measure when defining DE in terms of mRNA/transcriptome.
Hence, choosing a normalization method for an RNA-Seq experiment must begin with choosing a
definition of differential expression.
Once differential expression is defined, the next step is to determine which assumptions are
appropriate for the experiment at hand, and then choose a method that follows those assumptions.
Assumptions of each method depend on the definition of differential expression; in this paper, we
consider the assumptions necessary for each method under mRNA/cell differential expression. How-
ever, these assumptions will not be the same for mRNA/transcriptome differential expression. For
example, the assumption for library size normalization discussed above is that the total mRNA/cell
is the same under each condition. This assumption is necessary for the relative measures of ex-
pression obtained via library size normalization to be valid measures of absolute expression. If a
relative definition of DE is used instead, such as mRNA/transcriptome, then it is not necessary to
assume equivalent total mRNA/cell across conditions.
If spike-ins can be trusted, they are important to use in normalization because there may be
previously unknown shifts in expression that cannot be detected without controls, and housekeeping
genes do not seem a reliable choice for controls. RUV aims to address the shortcomings of spike-ins,
so may be a good method to use when spike-ins are available.
However, there are situations in which spike-in methods are not an option. Coate and Doyle [24]
note that application of spike-in methods requires the ability to count the number of cells used in
RNA extraction, and cell counting is not possible in some tissue types. In these cases, normalization
by distribution/testing appears to be the best option, and DESeq especially has generally been
shown to perform well.
CONCLUSION
The use of RNA-Seq experiments to study organisms’ genomes is becoming ubiquitous, and
the explosion in the use of sequencing technology has led to a related explosion in the develop-
ment of statistical methods for processing and analyzing RNA-Seq data. As previous research has
demonstrated [10], proper normalization is an essential step in the analysis pipeline. We have seen
that incorrect normalization can result in downstream errors such as inflated false positives. The
need for normalization arises from the inherent variability in the collection of RNA-Seq data, and
a variety of normalization methods have been devised to combat this variability. As we have seen,
the literature has not reached a consensus on which normalization method to use.
Each normalization procedure relies on assumptions, and when violated the procedures lead to
incorrect results. For each assumption, there is evidence that it may not hold in some experiments.
Part of an analysis of RNA-Seq data requires choosing a normalization procedure, and keeping the
assumptions of each method in mind can help to make the appropriate choice for the experiment
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at hand. However, there may be many situations in which the validity of any assumption is
unknown for the given experiment. In such cases, normalization with external controls would be
the appropriate choice if the external controls can be trusted. Unfortunately, several authors have
found problems with spike-ins and so propose additional methods to handle these issues. It is clear
that spike-ins are necessary in some circumstances, and we hope that as research progresses their
performance will improve.
To the best of our knowledge, there does not exist an extensive analysis of published data
which evaluates the assumptions of normalization methods. Given the potential violations to
each normalization assumption, knowledge of the extent to which each assumption holds in a
given experiment would be instrumental in helping to choose a normalization method for RNA-Seq
analysis. There is no clear way to perform such an evaluation, however, considering that violations
of assumptions (such as a global shift) may go undetected without additional information and the
requisite information may not be present in the original experiment.
SUPPLEMENTARY INFORMATION
The False Discovery Rate
Following the notation of Benjamini and Hochberg [36], suppose there is a family of m inde-
pendent hypotheses to be tested, m0 of which are truly null. We represent the different possible
outcomes in Table 2.
Declared Declared Total
non-significant significant
True null hypotheses U V m0
Non-true null hypotheses T S m−m0
m−R R m
Table 2: True discoveries and false discoveries when testing m null hypotheses [36].
Definition 1. The false discovery rate. From Table 2, the proportion of discoveries which are
false is V/R, and the false discovery rate is defined to be
FDR = E(V/R)
where V/R = 0 whenever R = 0. In other words,
FDR = E(V/R|R > 0)P (R > 0).
To control the FDR at a desired level α, Benjamini and Hochberg proposed the following step-up
procedure (henceforth referred to as BH) [36].
Definition 2. BH procedure. Let p1, ..., pm be the p-values resulting from tests of the m hy-
potheses, and p(1), p(2), ..., p(m) the p-values in increasing order. The BH procedure finds the
largest index i such that
p(i) ≤ α
i
m
and then p(1), ..., p(i) are declared significant, and their associated hypotheses rejected. Equivalently,
each p-value p(i) is adjusted by setting p(i) = min{mj p(j) : j ≥ i}, then all p-values below the cutoff
α are rejected.
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Benjamini and Hochberg proved that this procedure controls the FDR at
FDR ≤ αm0
m
≤ α
and furthermore that the cutoff T = max{p(i) : p(i) ≤ α im} can be less stringent than the cutoff
given by FWER control, since FWER control implies FDR control but a procedure controlling the
FDR need not necessarily control the FWER [36].
In the two decades since the introduction of the FDR, a number of alternative approaches have
been suggested, including related errors like Storey’s positive false discovery rate (pFDR) [42], and
adaptive methods for controlling the FDR while attempting to maximize power, such as the one
proposed by Storey and Tibshirani [43]. Other methods and procedures attempt to control FDR
in more complicated scenarios. The common goal of all these varied methods is to maintain error
control in different situations while conserving as much power as possible.
While more advanced methods than the BH procedure are demonstrably better at controlling
FDR, in the sense of maintaining control while increasing power (the method proposed in [43] is
one such example) the most common choice appears to still be BH, and is in fact the default in the
several DE packages. For this reason, FDR control performed in simulations in this paper is done
using BH.
Details on Normalization
Here we provide more specifics on the normalization procedures mentioned in the body of the
text.
Total Count: Total count normalization deals with the most observable difference in RNA-Seq
samples: their library sizes. In total count normalization [9], read counts are normalized by dividing
each count by the total number of reads in its sample. The goal of total count normalization is to
account for differences in library size by simply dividing by library size in each sample.
RPKM: RPKM (reads per kilobase per million mapped reads) normalization [26] is an adap-
tation of total count normalization that attempts to normalize by gene length as well as the total
number of reads in each sample. As the name suggests, in RPKM normalization each read count
is normalized by dividing by the number of reads in the sample (in millions) and the gene length
(in kilobases).
FPKM: FPKM (fragments per kilobase per million mapped fragments) normalization [27] is
almost exactly the same as RPKM normalization, with the change of using cDNA molecules rather
than RNA reads; each cDNA molecule corresponds to two reads, each starting at a different end of
the fragment.
Quantile: Before the use of RNA-Seq experiments was common, a huge body of work was
developed for the analysis of microarray data. Quantile normalization is the result of applying a
normalization method used in microarray analysis to RNA-Seq data. The basic algorithm is as
follows, and is designed to make use of the fact that data vectors with the same distribution will
have their quantiles plotted on the diagonal, by forcing the normalized data to have quantiles on
the diagonal and hence have the same distribution [28]:
1. Sort each column of the read count matrix; this causes each row to contain the same quantiles
of each sample.
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2. Replace each entry in the sorted read count matrix with the mean of that row.
3. Undo the sorting on the read count matrix, so that the entries are now back in the original
order.
Using this algorithm, the read count matrix has been normalized so that each sample is forced to
have the same distribution over all the genes. Other measures such as the median could be used in
place of the mean of the quantiles.
Upper Quartile: Upper quartile normalization [10] is similar to quantile normalization but
focuses on one specific quantile (the 75th percentile). In upper quartile normalization, each read
count is divided by the 75th percentile of the read counts in its sample, where genes with read
counts of 0 across all samples are excluded. Zyprych-Walczak et al. [16] also report a variant of
Upper Quartile normalization in a rather complicated form that ultimately reduces to scaling each
Upper Quartile normalization factor by the geometric means of the Upper Quartiles, so that the
product of the normalization factors is 1.
Median: Median normalization [9] is essentially the same as Upper Quartile normalization,
except that gene counts are scaled by the median of counts in their sample rather than the 75th
percentile.
DESeq: The DESeq normalization strategy attempts to find a size factor for each sample, such
that the ratios of size factors of different samples represent the ratio of their respective sequencing
depths. Let kij be the number of reads aligned to gene i under sample j. The estimated size factor
sˆj for sample j is given by
sˆj = mediani

kij(
m∏
v=1
kiv
)1/m

where m is the total number of samples, across all conditions. The denominator
(
m∏
v=1
kiv
)1/m
serves as a pseudo-reference sample to which each sample can be compared. As discussed in [25],
the rational behind the size factor estimation is that a good estimate for the ratio of sequencing
depths of two samples should be the median of the ratios of their counts. This is generalized to
multiple samples through the use of the pseudo-reference sample.
CuffDiff: Introduced by Trapnell et al. [44] as part of the CuffDiff 2 software, the CuffDiff nor-
malization method is a slight modification of the DESeq method. The CuffDiff approach calculates
two different normalization factors: an internal scale is used when comparing samples taken under
the same biological conditions, while an external scale is used to compare samples across different
biological conditions.
Calculation of the internal scale is simply a restriction of the DESeq normalization method to
the read count sub-matrix for each set of replicates; in an experiment with two conditions A and
B and three replicates per condition, for example, the DESeq method would be applied to both
groups of replicates separately, taking three columns of the matrix with each application.
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The external scale is calculated after the internal scale; in the case of 5 samples per condition and
two conditions, the result would be 10 size factors. Let sˆj denote the internal size factor for sample
j. We then use the internal size factors to normalize each column (divide by the corresponding
internal size factor). For each gene and each condition, we average the internal-scaled counts for the
replicates in that gene and condition; let ki,A and ki,B denote these averages for gene i in the case
of two conditions. That is, with kij again denoting the (i, j) entry of the full read count matrix,
ki,A =
1
mA
∑
j:ρ(j)=A
kij
sˆj
and likewise for ki,B, where mA is the number of samples performed under condition A and ρ(j)
denotes the condition under which sample j was performed. We then use the ki,ρ(j) values to
produce external size factor estimates
ηj = mediani
ki,ρ(j)
∏
ρ(v)
ki,ρ(v)
−1/c

where c is the number of conditions. To compare internal-scaled counts across different conditions
(such as for DE testing), we adjust the internal-scaled counts using the external scale.
TMM: TMM (Trimmed Mean of the M-values) [7] is a normalization strategy with a very
similar approach to the DESeq size-factor estimate. TMM sets one of the samples as a reference
sample, then compares the counts in each sample to the reference sample to estimate the ratio of
sequencing depths between each sample and the reference. The procedure involves trimming genes
twice, using both the fold-changes and expression levels between samples; the goal is to remove
genes that are differentially expressed, so that the mean can be taken over genes that do not show
differential expression. For these genes, we expect that the ratio of counts in one sample to the
reference sample is represented by the ratio of the sequencing depths.
Let kij again denote the number of reads aligned to gene i under sample j. Let µij be the true
gene expression level of gene i under sample j, and Nj the total number of reads for sample j,
i.e. the library size
(
Nj =
∑
i
kij
)
. Fixing one of the samples r as the reference sample, we define
gene-wise log fold changes
M rij = log2
kij/Nj
kir/Nr
and absolute expression levels
Arij =
1
2
log2
(
kij
Nj
· kir
Nr
)
.
For sample j, the M rij and A
r
ij values are trimmed independently (the default amount trimmed is
30% for the M rij and 5% for the A
r
ij) to produce a set of genes G for which neither the M
r
ij nor
Arij value was removed (trimmed). Using this set G, we calculate the scaling factor TMM
(r)
j for
sample j via a weighted mean:
log2(TMM
(r)
j ) =
∑
i∈G
wrijM
r
ij∑
i∈G
wrij
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where
wrij =
Nj − kij
Njkij
− Nr − kir
Nrkir
.
Note that in the calculation of the scaling factors, we divide by the library size of each sample
(Nj). Thus, the TMM
(r)
j scaling factors tell us the relative size of samples after we have normalized
by library size, and to normalize so that read counts are directly comparable between samples we
would divide each sample by TMM
(r)
j ·
Nj
Nr
where Nr is the library size of the reference sample.
Median Ratio: Similarly to how CuffDiff normalization extends the DESeq normalization
procedure, Median Ratio normalization (MRN) [14] is designed to be a more robust adaptation of
the TMM method. As in the TMM method, define kij to be the number of reads aligned to gene
i under sample j and Nj the number of reads in sample j (its library size). And like the TMM
method, the MRN method separates library size normalization and normalization of the samples
after dividing by library size. Here, as in [14], we will describe MRN in the special case where there
are two experimental conditions A and B, although the method can be generalized to more than
two conditions.
MRN begins by taking the mean of library-normalized counts for each gene within each condi-
tion:
kiA =
1
mA
∑
j:ρ(j)=A
kij
Nj
would define this mean for condition A, and the definition is analogous for condition B. Then, we
calculate the ratio τi of these two means for each gene i:
τi =
kiB
kiA
.
We define τ to be the median of these ratios across all genes. The intuition is that between two
samples of the same experimental condition, the difference in sequencing depth can be determined
directly by the difference in library size since there are no genes which can be differentially expressed
within the same biological condition. Then, normalization by library size puts samples within the
same condition on the same scale. Any remaining differences in normalized read counts within a
replicate group are then due to randomness, and so we can remove some of that natural variability
by averaging across samples within a replicate group. Then, τ represents the median relative size
of samples under each condition after accounting for library size; to get the normalization factor
for the original read count matrix, we include the library size:
ej =
{
Nj if ρ(j) = A
τ ·Nj if ρ(j) = B
Then, dividing each column of the original read count matrix by its corresponding normalization
factor will allow for direct comparison of reads across different samples and conditions. The final
step is to make the product of the normalization factors be 1 by dividing by their geometric mean,
which does not change the relationship between them but ensures that the normalized read counts
will be on a similar scale as the originals. Let f˜ =
(
m∏
v=1
ev
)1/m
where m is the total number of
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samples across all conditions. Then, the final normalization factor for sample j is
fj =
ej
f˜
PoissonSeq: The information for normalization is found in the non-differentially expressed
genes. TMM explicitly aims to remove differentially expressed genes through trimmed means,
leaving the non-DE genes as the set of genes used in estimates. Methods like Upper Quartile
normalization, DESeq, and MRN address the issue by examining a quartile of the data, or a
transformed version of the data, that is expected to be reasonably representative of the non-
differentially expressed genes. In the PoissonSeq method [30], developed as part of the PoissonSeq
package, the idea of using the non-differentially expressed genes is taken a step further by directly
performing a goodness-of-fit test to try to find a subset of non-differentially expressed genes.
Let Kij be the random variable for the number of reads aligned to gene i under sample j. It
is assumed in the PoissonSeq package that Kij ∼ Poisson(µij), although for the purposes of the
normalization technique the most salient point is using µij to denote the expectation of Kij , and
the actual distribution of Kij is less important for normalization than for performing tests for
differential expression. We model µij using
log(µij) = log(dj) + log(βi) + γi,ρ(j)
where dj is the sequencing depth for sample j, βi is the level of expression of gene i, and γi,ρ(j)
represents how associated the expression of gene i is with the condition ρ(j) of sample j. If γi is 0
for all conditions, then there is no association between the expression of gene i and the biological
conditions and hence gene i is not differentially expressed in the study. Under the null hypothesis
that there is no association between gene i and the condition of sample j, γi,ρ(j) = 0.
We estimate the expression level of gene i as βˆi =
m∑
v=1
kiv where m is the total number of
samples across all conditions. Since sequencing depth can be compared across samples using non-
differentially expressed genes, given a set S of non-differentially expressed genes we can compute an
estimate for the sequencing depth of sample j by the proportion of reads aligned to non-differentially
expressed genes that come from sample j:
dˆj =
∑
i∈S
kij
∑
i∈S
(
m∑
v=1
kiv
) =
∑
i∈S
kij∑
i∈S
βˆi
.
For genes in S, γi,ρ(j) = 0 and so log(µij) = log(djβi). Hence, an estimate for E(kij) is dˆj βˆi
and we can create a goodness-of-fit statistic for each gene i:
GOFi =
m∑
v=1
(kij − dˆj βˆi)2
dˆj βˆi
.
We ultimately want a good estimate of dj , which means we want to identify S. To do so, we start
with an initial estimate of dj using the entire set of genes as S, then calculate GOFi statistics and
take the middle (1 − 2ε) · 100% and re-calculate dˆj . We then alternate between estimating S and
dj until convergence. By default, PoissonSeq uses ε = 0.25. The final sequencing depth estimates
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dˆj are then scaled so that their product is 1.
DEGES: This normalization approach [11], which stands for Differentially Expressed Gene
Elimination Strategy, has a very similar approach to PoissonSeq. It alternates between estimating
normalization factors and using those normalization factors to determine which genes are dif-
ferentially expressed. We will describe the algorithm without relying on a specific strategy for
normalization or testing.
1. Using all genes in the experiment, calculate normalization factors for each sample. For exam-
ple, if we used DESeq normalization, we would calculate the median of the relative expression
values across all genes.
2. Using the normalization factors from Step 1, perform differential expression hypothesis testing
and identify a set of non-differentially expressed genes.
3. Re-calculate normalization factors using the set of genes identified in Step 2.
The algorithm alternates between Steps 2 and 3 a prespecified number of times, the idea being to
iteratively improve normalization. The final normalization factors can then be used in an official
differential expression analysis.
Housekeeping Genes: If one can identify a priori a set of non-DE genes, these could be
used for normalization purposes. For example, Bullard et al. [10] investigates the use of house-
keeping genes, specifically POLR2A, to perform normalization. With one gene, all read counts
in a sample are scaled by a single factor, so that after normalizing each sample the read counts
for the housekeeping gene are the same across all samples. With multiple housekeeping genes,
typical normalization methods can be applied to the set of housekeeping genes rather than to all
genes. For example, DESeq normalization could be applied to the read count matrix restricted to
the housekeeping genes, then the size factor estimates obtained would be applied to normalize the
entire read count matrix as usual.
Spike-in Controls: As with housekeeping genes, typical normalization methods like Upper
Quartile and DESeq can be applied to only the spike-in controls [33], producing normalization
factors that are then applied to all genes. Another spike-in method was proposed by Love´n et al.,
who used loess normalization to normalize the RPKM values for all genes to the spike-in RPKM
values [23]. As in Love´n et al. [23], spike-in normalization typically requires that the spikes be
added in proportion to the number of cells from which the sample RNA is extracted [24]; this
ensures that the spikes will have the same RNA/cell in each condition. Changes in the proportion
of reads aligned to the spikes in a sample then indicate changes in the amount of mRNA/cell for
the genes, which can be reflected in the read counts by adjusting counts to equilibrate the spike-in
counts across samples (see Figure 4).
Loess normalization, originally developed to normalize microarray intensities, can also be ap-
plied to normalize RPKM values. The method works as follows [23,28], and compares two samples
at a time. First, M and A values for each gene/spike-in i are calculated between samples j and k
(similar to the M-A values calculated in TMM):
Mi = log2
(
RPKMij
RPKMik
)
Ai =
1
2
log2 (RPKMij ·RPKMik)
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Consider the Mi values for the spike-ins. Since the spike-ins should be non-DE, then we would
expect each Mi value to be 0. Thus, we want to adjust the Mi values so that when we plot adjusted
Mi against Ai, the adjusted Mi values are scattered around 0. To do so, plot the Mi against Ai for
the spikes and fit a loess curve to the data (note that the loess curve is fit only with the spike-ins);
let Mˆi be the fitted value on the curve for each gene/spike. Then, the adjusted Mi value is
M ′i = Mi − Mˆi.
All genes, not just the spike-ins, are adjusted in this way. Since the loess curve was calculated
using only the spike-ins, M ′i for the spike-ins will be centered around 0 as desired, but we avoid
centering all genes around 0 and so are still able to detect shifts in expression.
To calculate the re-normalized values, RPKM ′ij and RPKM
′
ik,
RPKM ′ij = 2
Ai+
M′i
2
RPKM ′ik = 2
Ai−M
′
i
2 .
Re-normalized RPKM values are calculated for each pair of samples, then the original RPKM val-
ues are corrected using each of the pairwise corrections.
Remove Unwanted Variation: Adapted from previous work on normalization of microar-
ray data, the Remove Unwanted Variation [33] (RUV) method aims to remove variation between
samples that is not the result of the biological covariates of interest. The notation associated with
this method will differ from that used in the other normalization procedures described above, as
the method is sufficiently complicated that it is easiest to communicate by being consistent with
the original paper.
Suppose an RNA-Seq experiment is performed with J genes and n samples, and p covariates of
interest. We will restrict our examination of this method to the classic case of a differential study
with two conditions. In this case, p = 2.
• Let Y ∈ Mn×J be the read count matrix, so Yij corresponds to the number of reads aligned
to gene j in sample i.
• Let X ∈ Mn×p denote the design matrix for the experiment. In our restricted case, the design
matrix has a column for the intercept and each entry in the second column is an indicator
for whether the sample corresponding to that row is under condition A or condition B.
• Let W ∈ Mn×k be a matrix related to k factors of unwanted variance (k must be specified
beforehand).
• Let α ∈ Mk×J be the coefficients corresponding to the factors of unwanted variance in W .
• Let β ∈ Mp×J be the coefficients which represent the relationship between each gene and each
covariate of interest.
• Let O ∈ Mn×J be a matrix reflecting sequencing depth offsets; the authors suggest using
Upper Quartile normalization, though of course other methods would also work in its place.
Then, we assume the log-linear model
logE[Y |W,X,O] = Wα+Xβ +O. (1)
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The RUV method provides three different sub-procedures to approach normalization given this
model, with varying assumptions. RUVg uses that a set of negative control genes (which can be
spike-in controls) is known. RUVr uses the residuals of a first-pass fit to the log-linear model in
Equation (1) and does not require knowledge of negative control genes, though does assume that
the factors of unwanted variation are uncorrelated with the biological conditions. RUVs creates
negative control samples by comparing samples within replicate groups, and also relies on negative
control genes and the factors of unwanted variation being uncorrelated with the biological conditions
in the experiment. The difference between RUVs and RUVg is that RUVs is designed to be more
robust to the choice of negative control genes, and the authors state that the method can still
perform reasonably even when the entire set of genes is used.
The three RUV paths are reasonably similar, and so for sake of brevity only one (RUVg) will
be described here; notation is borrowed from Risso et al. [33]. We begin by assuming that there is
a set of Jc negative control genes. When the matrices in Equation (1) are restricted to the negative
control genes, we will use the subscript c.
1. Define Zc = log Yc − Oc, so that we have accounted for offsets in the experimental data.
This should make samples of different sequencing depths comparable. Then let Z∗c be the
column-centered version of Zc. After accounting for sequencing depth, the only variation of
negative control genes across samples is from factors of unwanted variation. By subtracting
the mean of each column, the measurement of the expression of each gene in Z∗c is centered at
0, which also allows the intercept term to be 0 in βc. Since none of the genes are associated
with the biological covariates of interest, the other coefficients in βc will be 0 as well, yielding
Z∗c = Wαc.
2. Next, perform the singular value decomposition of Z∗c , so Z∗c = UΛV T where Λ is the rect-
angular diagonal matrix of singular values of Z∗c .
3. For a given number k of factors of unwanted variation, we are interested in determining the
impact of those factors so we reduce to only the k largest singular values. Denote by Λk
the n × Jc matrix obtained from Λ by setting all singular values but the k largest to 0. We
estimate W by Wˆ = UΛk where we have removed columns of 0s to ensure that Wˆ ∈ Mn×k.
Under the assumption that the factors of unwanted variation for the negative control genes
span the same space as the factors of unwanted variation for all genes (in the linear algebra
sense, since columns of W are factors of unwanted variation and Wα is a linear combination
of the columns of W ), then Wˆ will estimate W .
4. Substituting Wˆ back into Equation (1), and with knowledge of the design matrix X, GLM
regression can be used to estimate the remaining parameters α and β, and then differential
expression analysis can be performed. Though the authors do not recommend obtaining
normalized counts separately from the differential expression analysis procedure, it is possible
to use RUVg to normalize by performing OLS regression of Z = log Y −O on Wˆ . The residuals
of this regression are the normalized read counts.
We also present some intuition to further explain RUVg. We don’t care about W or α separately,
as the normalization considers only their product Wα. As Wα is a linear combination of the
columns of W , then Wα could be represented infinitely many ways by replacing the columns of W
with another set of vectors spanning the same space and replacing α by the correct coefficients to
get the same linear combination with the new spanning set. Hence, if we assume that the factors of
unwanted variation for the negative control genes span the same space as the factors of unwanted
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variation for all genes, then W can be calculated using only the negative control genes since we
just need to span the same space rather than get exactly the same matrix.
KEY POINTS
• Assumptions allow normalization to translate raw read counts into meaningful measures of
expression.
• The correct normalization method to use depends on which assumptions are valid for the
biological experiment.
• Incorrect normalization leads to problems in downstream analysis, such as inflated false pos-
itives, that mean results cannot be trusted.
• There are examples of global shifts in expression that violate assumptions of conventional
normalization methods, requiring controls.
• No normalization method is perfect, and for every method there exists cases for which the
assumptions are violated.
• An understanding of assumptions can help pick the most suitable normalization method for
a given experiment.
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